For Friday, November 18th
PARD, EVCA, PRPH, FTWR, HPGS, CRPZ
Our Stocks to Watch today include Poniard Pharmaceuticals Inc. (NASDAQ: PARD), EVCARCO Inc. (OTCBB: EVCA), ProPhase Labs Inc. (NASDAQ: PRPH), FiberTower Corp. (NASDAQ: FTWR), High Plains Gas Inc. (OTCBB: HPGS) and Convenience TV Inc. (OTCBB: CRPZ).
STOCKS TO WATCH
PONIARD PHARMACEUTICALS INCORPORATED (NASDAQ: PARD)
"Up 103.28% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PARD.php
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. Poniard's lead product candidate is picoplatin, a new generation platinum-based cancer therapy designed to treat solid tumors that are resistant to existing platinum-based therapies. Assuming receipt of shareholder approvals and satisfaction of other conditions to closing, the merger of Poniard and ALLOZYNE, Inc. will result in a Nasdaq-listed specialty pharmaceutical company focused on developing and commercializing therapeutics in the areas of autoimmune and inflammatory disease and cancer. The combined company is expected to seek a partnership for the continued development of picoplatin.
PARD News:
November 17 - Poniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase Technology
Poniard Pharmaceuticals, Inc. (NASDAQ: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced today that it has entered into a licensing agreement with an undisclosed party for rights to Poniard's focal adhesion kinase (FAK) technology, including a preclinical candidate that is a selective small molecule inhibitor of FAK.
Under terms of the agreement, Poniard granted the licensee worldwide rights for the development and commercialization of any FAK-related products, including the preclinical candidate, in exchange for an upfront cash payment of $250,000, milestone payments and other considerations, as well as royalty payments on net sales of any products covered by the license. The licensee is responsible for all costs related to further development and commercialization.
Also known as protein tyrosine kinase 2 (PTK2), FAK is associated with the invasion and metastasis of tumor cells. Inhibition of FAK activity is thought to decrease the mobility of certain cancer cells, reducing the potential for metastases. FAK is also thought to play a role in tumor formation and progression. Poniard's FAK technology was developed through a research funding agreement with The Scripps Research Institute.
"Poniard's FAK technology includes novel inhibitors against a pathway which plays a potentially critical role in the proliferation of cancer," said Ronald A. Martell, chief executive officer of Poniard. "Our discovery and early research efforts in this area began in 2005 under a funded research agreement with the Scripps Research Institute. We look forward to the advancement of this technology and the opportunity to realize potential value through out-licensing and through our proposed merger with ALLOZYNE, which is subject to shareholder approvals."
EVCARCO INCORPORATED (OTC: EVCA)
"Up 33.33% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/EVCA.php
Evarco Inc. is the Future Driven® automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. Evarco is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. Evarco has developed a dealer network allowing growth into most US States by 2012.
EVCA News:
November 14 - EVCARCO Updates Shareholders and Investment Community
EVCARCO Inc. (OTCBB: EVCA) updated shareholders regarding an upcoming amendment to the Articles of Incorporation and recent corporate developments.
Operations
As the Company continues to search for reliable car manufacturers that produce environmentally friendly vehicles, it continues to operate at its current location in Ft.Worth, Texas, and to generate revenues in the pre-owned market. Operations have generated gross revenues of $887,775 for 2009, $804,772 for 2010, $118,401 for the first quarter of 2011, and $230,695 for second quarter of 2011. The quarterly report for third quarter of 2011 is scheduled to be released next week.
Acquisitions Efforts
The Company over the previous several months has made offers to several dealership owners, to acquire their existing new car operations in the Dallas-Ft.Worth Metroplex, but was unsuccessful in reaching an agreement. EVCARCO will continue with its current operations and in reviewing other strategic acquisition opportunities.
Corporate Structure
After careful consideration, the Board of Directors of EVCARCO has decided that in the best interest of the Company and its shareholders, it is necessary to increase authorized capital in order to facilitate possible acquisitions, raise additional capital, and to refocus the Company for a new phase of growth and increase in shareholder value. On November 9, 2011, EVCA filed a Schedule 14C Information with the SEC, to notify the shareholders about the amendment to its Articles of Incorporation to increase the number of shares of Common Stock as well as Class B Convertible Preferred Stock. The amendment is set to be effective on November 30, 2011.
Mack Sanders, CEO of EVCARCO, stated, "In a tough automotive climate, EVCARCO continues to focus on growth and exploring opportunities. We believe that our motto, Future Driven®, has never been stronger and as a veteran of the automotive industry for more than 25 years, I can certainly tell you that the EVCARCO team will continue to adapt, expand, and adjust to all aspects of these changing times."
PROPHASE LABS INCORPORATED (NASDAQ: PRPH)
"Up 22.86% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PRPH.php
ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold relief products. Cold-EEZE® zinc gluconate lozenges are clinically proven to shorten the duration of the common cold by nearly half. Cold-EEZE® customers include leading national retailers, food, chain drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase's robust over-the-counter distribution channels.
PRPH News:
November 17 - Cold-EEZE® Cold Remedy Awarded Coveted Parent Tested Parent Approved (PTPA) Seal of Approval
ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE Cold Remedy, a leader in over-the-counter (OTC) homeopathic cold remedies, is excited to announce that Cold-EEZE has been awarded the Parent Tested Parent Approved (PTPA) Winner's Seal of Approval. PTPA Media has North America 's largest volunteer parent testing community, with over 40,000 parents. The seal of approval was awarded based on quality, effectiveness and value.
Cold-EEZE is the #1 pharmacist-recommended zinc cold remedy. Its proprietary zinc gluconate formula is clinically proven to safely and effectively reduce the duration and the severity of the symptoms of a common cold by nearly half (42%).
"This Seal of Approval reflects the high standards that we set for Cold-EEZE, and we are honored to receive this award," says Ted Karkus , Chairman and Chief Executive Officer of ProPhase Labs. "This recognition highlights the benefits and value that Cold-EEZE offers to families during the cough and cold season."
Cold-EEZE was among many entries from across North America competing to earn the PTPA™ Seal. Independent parent volunteers evaluate these products in their own homes. Therefore, PTPA winners are chosen based on merit and consumer experience – not on commercial considerations. As a result, the PTPA Media™ Seal has quickly gained recognition as an international leader in certifying consumer products for quality, effectiveness and value. PTPA's CEO and founder, Sharon Vinderine, has appeared on over 40 morning shows as a reliable source for the latest and greatest in family products. The media and parents alike trust the collective opinion that PTPA Media represents.
"At PTPA Media, we are proud to play a role in certifying innovative products that families can trust," says Vinderine. "When consumers search for our Seal of Approval on product packaging and web sites, they are essentially searching for validation from their peers. Their peers will have objectively tested and approved these products based on their performance in a real life environment. That type of resource for families is priceless."
Cold-EEZE Cold Remedy has recently introduced a new convenient and great tasting Oral Spray version. Just two sprays of the Oral Spray deliver the same amount of cold remedy (active ingredient zinc gluconate) as one Cold-EEZE lozenge. Cold-EEZE is available at over 40,000 fine retail locations including all major food stores, drug chains and mass retailers.
FIBERTOWER CORPORATION (NASDAQ: FTWR)
"Up 18.32% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/FTWR.php
FiberTower is a backhaul and access services provider focused primarily on the wireless carrier market. With its extensive spectrum footprint in 24 GHz and 39 GHz bands, carrier-class microwave and fiber networks in 13 major markets, customer commitments from six of the leading cellular carriers, and partnerships with the largest tower operators in the U.S., FiberTower is considered to be the leading alternative carrier for wireless backhaul. FiberTower also provides backhaul and access services for government and enterprise markets.
FTWR News:
November 16 - FiberTower Announces Reduction in Force
FiberTower Corporation (NASDAQ: FTWR), a wireless backhaul services provider, announced that it has reduced its workforce approximately 40%, and has halted all capital and project related spending in an effort to conserve existing liquidity. Remaining staff will be focused on maintaining the Company's network and day-to-day operations as management makes decisions about future actions.
HIGH PLAINS GAS INCORPORATED (OTC: HPGS)
"Up 30.87% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/HPGS.php
High Plains Gas, Inc. is a Gillette, Wyoming based energy company actively engaged in the acquisition, development and production of natural gas primarily in the Powder River Basin. The Company’s assets include the former Marathon “North & South Fairway” assets. These assets consist of 1614 Coal Bed Methane Wells with associated flow lines and over 155,000 net acres. This combined with the company’s existing 92 natural gas wells gives the company a strong foundation in the natural gas industry. High Plains Gas intends to continue to pursue expansion opportunities for the profitable production and transmission of natural gas. High Plains Gas believes it has unique expertise and experience in the refurbishment and reactivation of wells that produce natural gas from coal bed methane formations that helps position it strategically in the Powder River Basin. In 2011, the Company formed a subsidiary, High Plains Gas Services, LLC, focused on providing construction and maintenance services to the energy industry, primarily in the Western United States.
HPGS News:
November 17 - Steps in the Right Direction — Featured Research on BioFuel Energy Corp. and High Plains Gas Inc
The BollingerReport.com introduced featured coverage of BioFuel Energy Corp. (NASDAQ: BIOF) and High Plains Gas Inc. (OTCBB: HPGS). Full research reports are available to readers at www.BollingerReport.com.
With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% cut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.
Bollinger Report screened and selected BioFuel Energy Corp. for its current position within the basic materials industry. BioFuel Energy Corp. produces and sells ethanol and its co-products (primarily distillers grain), through its two ethanol production facilities located in Wood River, Nebraska and Fairmont, Minnesota. The Company's ethanol plants are owned and operated by the Operating Subsidiaries of the BioFuel Energy, LLC, (the LLC).
Bollinger Report is featuring High Plains Gas Inc. for its changing role within the industry. High Plains Gas, Inc. (High Plains), formerly Northern Explorations, Ltd., is an exploration and production company. It is a natural gas and petroleum exploration, development and production company, engaged in locating and developing hydrocarbon resources, primarily distressed and/or orphaned oil and gas projects throughout the Rocky Mountain region.
CONVENIENCE TV INCORPORATED (OTCBB: CRPZ)
"Up 12.50% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CRPZ.php
Convenience TV is focused on the Convenience Store Industry and provides their clients with an "in-location" TV network. The Network is designed to deliver both entertaining content and targeted advertising on a demographic basis to each retail location. In addition, the Network delivers promotional advertising tied to products within the retail location. The programming can be updated quickly and is tailored to meet the specific clients' need for increased sales, customer enjoyment and brand reinforcement.
CRPZ News:
November 17 - Convenience TV Announces Preliminary Financing Commitment
Convenience TV Inc. (OTCBB: CRPZ) announced a Preliminary Financing Commitment of US$5,000,000 from Hyperscale Computing Group, LLC. in connection with Convenient TV's proposed acquisition of the Go Media business division currently operated by HFT Management Inc. The loan would mature in 3 years, carry an interest rate of 6.5% and be secured by all assets of Go Media.
A 30-day Due Diligence period began on November 1, 2011 with the acceptance of the Financing Commitment from Hyperscale. This due diligence period provides for Hyperscale's review and inspection of material transaction documentation, existing business contracts/arrangements, financial statements and operational projections by Go Media, as well as those of Convenience TV.
Unless otherwise mutually agreed, all documentation contemplated by Financing Commitment is expected to be executed and delivered on December 16, 2011, and the transaction closed on or before December 30, 2011 (the "Closing Date").
|
